779 — Manhattan, Kansas

779 is a clinical research site located in Manhattan, Kansas, United States.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

779 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy, Monotherapy.

Sponsors: UCB BIOSCIENCES GmbH.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 779?

779 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 779 conducted?

779 has 1 clinical trials on record. Their work covers Epilepsy, Monotherapy.

Is 779 accredited by Crixeo Health?

779 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 779?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.